Related Experiment Video

Updated: May 28, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

HIV-1 infection and neurocognitive impairment in the current era

María del Palacio1, Susana Alvarez, M Ángeles Muñoz-Fernández

  • 1Laboratorio Inmunobiología Molecular, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Reviews in Medical Virology
|October 13, 2011
PubMed

Insights

Highly active antiretroviral therapy (HAART) improves life for HIV/AIDS patients but doesn't fully prevent neurological damage. Further research into HIV-1's central nervous system effects is crucial for new treatments.

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Background:

  • HIV-1 infection can cause severe cognitive, behavioral, and motor impairments, known as AIDS dementia complex (ADC) or HIV-related encephalopathy.
  • While highly active antiretroviral therapy (HAART) has significantly improved patient outcomes, it does not offer complete protection against neurological damage in HIV/AIDS.
  • HIV-1-associated dementia is a complex condition potentially arising from multiple mechanisms involving various intracellular signaling pathways.

Purpose of the Study:

  • To understand the causes of neurodegeneration in HIV-1 infection.
  • To identify factors influencing disease development in certain individuals.
  • To explore new therapeutic targets for improving disease outcomes in HIV-associated neurocognitive disorders.

Main Methods:

  • Review of existing literature on HIV-1 neuropathogenesis.
  • Analysis of intracellular signaling pathways implicated in neurodegeneration.
  • Examination of factors contributing to individual susceptibility to HIV-associated neurological disease.

Main Results:

  • HIV-1 infection impacts the central nervous system (CNS) through complex mechanisms.
  • HAART is essential for controlling CNS viral replication but requires complementary CNS-directed therapies.
  • Understanding CNS viral dynamics and inflammatory responses is key to eliminating HIV-associated neurocognitive disorders.

Conclusions:

  • Effective management of HIV-associated neurocognitive disorders requires a multifaceted approach.
  • Targeting specific intracellular pathways and inflammatory responses may offer new therapeutic avenues.
  • Continued research into HIV-1's neurological effects is vital for developing comprehensive treatment strategies.

More Related Videos

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...